Cerebras files for IPO

The story behind Cerebras' refile is not new financials but a structural cap-table surgery. The original 2024 S-1 disclosed G42, the UAE-based AI conglomerate, accounted for 83% of 2023 revenue and 97% of 2024 hardware sales — a concentration so severe it triggered a CFIUS national-security review that froze the listing. SiliconANGLE's reporting captured the political calculus directly: G42's inclusion made the deal politically risky enough that executives waited for new administration appointments rather than push forward into a regulatory wall. The October 2024 $1.1B raise at an $8.1B valuation kept the company funded but the IPO paperwork sat withdrawn for over a year.

What changed is not the absence of concentration risk but its replacement. G42 is reportedly off the new investor list, CFIUS clearance landed in late 2025, and OpenAI now occupies the same anchor-customer slot — committing over $20 billion across three years and 750 megawatts of deployed chips. Cerebras has effectively traded a foreign sovereign-aligned customer for a domestic AI hyperscaler, which is regulatorily palatable but does not actually diversify revenue. The same single-buyer fragility exists; it just wears a different jersey now.

Buried in the structure of the OpenAI deal is a financial mechanism that deserves more attention than the headline dollar number. OpenAI is not just buying compute — it received warrants to purchase up to 33.4 million Class N shares, with a path to a roughly 10% stake if its spend reaches $30 billion. This converts what would normally be a procurement contract into a hybrid customer-investor relationship where the buyer captures upside on the seller's equity appreciation driven by the buyer's own purchases.

The pattern echoes other recent AI-era arrangements (Microsoft-OpenAI, Nvidia's strategic investments in customers it also sells to) but inverts the polarity: here the customer is taking equity in the supplier, not the other way around. For Cerebras, this aligns OpenAI's incentives to keep deploying — every additional megawatt strengthens the warrant value — but it also means the IPO is partially pricing in a self-reinforcing flywheel that depends on OpenAI's own capex trajectory remaining intact. If OpenAI throttles spending, Cerebras loses both revenue and the credibility of the warrant-implied valuation simultaneously.

The financials Cerebras put on the table are objectively strong: $510M in 2025 revenue, a 76% YoY climb from $290.3M, and a swing to $87.9M of net income from a per-share loss of $9.90 to a $1.38 profit. The full revenue ladder — $24.6M in 2022, $78.7M in 2023, $290.3M in 2024, $510M in 2025 — describes a roughly 20x expansion in three years. That is the kind of curve that justifies a premium multiple in any market, let alone an AI-infrastructure one.

But the reported targeted valuation of $22-25 billion (with some reports up to $35B) implies a price-to-sales ratio of roughly 45x against $510M of revenue, a multiple notably above where Nvidia trades despite Nvidia's vastly larger profit base. The Techi analyst framing matters here: Cerebras is the first pure-play Nvidia alternative to reach public markets in this cycle, which creates a scarcity premium institutional investors may pay for diversification within their AI compute exposure. The risk is that the multiple is being supported less by intrinsic margin economics and more by the OpenAI deal narrative — a contract that, again, is concentrated in a single customer whose own future cash flows are still being negotiated.

The timing of this filing is not coincidence. The 2026 IPO calendar is shaping up around AI mega-listings (with SpaceX, OpenAI, and Anthropic also in the conversation), and a vocal r/investing thread on the dynamic — surfacing concerns about retail being positioned as exit liquidity for late-stage AI capital — captures the broader market mood. Into that backdrop, Cerebras lands as the cleanest pure-play wager on Nvidia not winning everything, which is exactly the diversification trade institutional AI portfolios have been trying to construct.

CEO Andrew Feldman's public posture is built for this moment. His claim that switching from Nvidia GPUs to Cerebras inference takes about ten keystrokes and under a minute is a direct attack on the CUDA-lock-in thesis that underpins Nvidia's terminal-value story. Whether the claim survives serious workload migration tests is a different question — but the narrative is calibrated to the exact concern allocators have when they look at their AI compute exposure and ask what would happen if the moat is thinner than priced. Cerebras is offering itself as the hedge, and the IPO is the vehicle for institutions to actually buy it.